Fielding, KL; Charalambous, S; Stenson, AL; Pemba, LF; Martin, DJ; Wood, R; Churchyard, GJ; Grant, AD; (2008) Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study. BMC infectious diseases, 8. p. 93. ISSN 1471-2334 DOI: https://doi.org/10.1186/1471-2334-8-93

Gupta, S; Yardley, V; Vishwakarma, P; Shivahare, R; Sharma, B; Launay, D; Martin, D; Puri, SK; (2014) Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis. The Journal of antimicrobial chemotherapy. ISSN 0305-7453 DOI: https://doi.org/10.1093/jac/dku422 Full text not available from this repository.

Hoffmann, CJ; Charalambous, S; Martin, DJ; Innes, C; Churchyard, GJ; Chaisson, RE; Grant, AD; Fielding, KL; Thio, CL; (2008) Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program. Clinical infectious diseases, 47 (11). pp. 1479-1485. ISSN 1058-4838 DOI: https://doi.org/10.1086/593104 Full text not available from this repository.

Thompson, AM; O'Connor, PD; Blaser, A; Yardley, V; Maes, L; Gupta, S; Launay, D; Martin, D; Franzblau, SG; Wan, B; +3 more... Wang, Y; Ma, Z; Denny, WA; (2016) Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis. Journal of medicinal chemistry. ISSN 0022-2623 DOI: https://doi.org/10.1021/acs.jmedchem.5b01699

Wong, SH; Lennon, DR; Jackson, CM; Stewart, JM; Reid, S; Ypma, E; O'Hallahan, JM; Oster, P; Mulholland, K; Martin, DR; (2009) Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine. [Conference or Workshop Item] https://doi.org/10.1097/INF.0b013e318195205e Full text not available from this repository.